Upgrade to SI Premium - Free Trial

Novan (NOVN)

1.22 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (2/13/23 *Est.)

Latest Headlines

Erasca Announces Exclusive Worldwide License for Pan-RAF Inhibitor Naporafenib December 9, 2022 7:34 AM - Globe NewsWire Novartis investigational iptacopan provides clinically meaningful increases in hemoglobin levels in complement-inhibitor-naïve patients with PNH December 8, 2022 1:26 AM - PR NewsWire Novartis Kisqali® prolonged PFS benefit for pre- and perimenopausal patients with aggressive HR+/HER2− metastatic breast cancer compared to chemotherapy December 6, 2022 1:45 PM - PR NewsWire Form 8-K Novan, Inc. For: Dec 01 December 6, 2022 6:31 AM - SEC Filing Form 6-K NOVARTIS AG For: Dec 05 December 5, 2022 9:28 AM - SEC Filing Top 5 stocks to end the year, according to Artificial Intelligence December 5, 2022 6:58 AM - StreetInsider EPI Health, a Novan Company, Executes a $15.0 Million Financing Agreement December 2, 2022 8:00 AM - Globe NewsWire EPI Health, a Novan Company, Executes a $15.0 Million Financing Agreement December 2, 2022 8:00 AM - StreetInsider Novan to Participate in the Cantor Fitzgerald Medical & Aesthetic Dermatology, Ophthalmology & Medtech Conference December 1, 2022 9:00 AM - Globe NewsWire Novan to Participate in the Cantor Fitzgerald Medical & Aesthetic Dermatology, Ophthalmology & Medtech Conference December 1, 2022 9:00 AM - StreetInsider Sandoz Canada launches PrSandoz® Apremilast November 15, 2022 9:25 AM - Globe NewsWire Form 10-Q Novan, Inc. For: Sep 30 November 14, 2022 7:17 AM - SEC Filing Novan (NOVN) Tops Q3 EPS by 14c November 14, 2022 7:13 AM - StreetInsider Form 8-K Novan, Inc. For: Nov 14 November 14, 2022 7:05 AM - SEC Filing Novan Reports Third Quarter 2022 Financial Results and Provides Corporate Update November 14, 2022 7:00 AM - Globe NewsWire Novan Reports Third Quarter 2022 Financial Results and Provides Corporate Update November 14, 2022 7:00 AM - StreetInsider Novan to Report Third Quarter 2022 Financial Results on November 14, 2022 November 7, 2022 9:00 AM - Globe NewsWire Novan to Report Third Quarter 2022 Financial Results on November 14, 2022 November 7, 2022 9:00 AM - StreetInsider Form 6-K NOVARTIS AG For: Sep 30 October 25, 2022 9:41 AM - SEC Filing Form 6-K NOVARTIS AG For: Oct 24 October 24, 2022 6:06 AM - SEC Filing EPI Health, a Novan Company, and MC2 Therapeutics Announce Data from Survey Conducted by National Psoriasis Foundation Presented at 42nd Annual Fall Clinical Dermatology Conference® October 21, 2022 8:35 AM - Globe NewsWire EPI Health, a Novan Company, and MC2 Therapeutics Present New Data In Multiple Posters Highlighting WYNZORA’s® Unique PAD Technology™ at the 42nd Annual Fall Clinical Dermatology Conference® October 21, 2022 8:35 AM - Globe NewsWire EPI Health, a Novan Company, and MC2 Therapeutics Announce Data from Survey Conducted by National Psoriasis Foundation Presented at 42nd Annual Fall Clinical Dermatology Conference® October 21, 2022 8:35 AM - StreetInsider EPI Health, a Novan Company, and MC2 Therapeutics Present New Data In Multiple Posters Highlighting WYNZORA’s® Unique PAD Technology™ at the 42nd Annual Fall Clinical Dermatology Conference® October 21, 2022 8:35 AM - StreetInsider Novan and EPI Health, a Novan Company, Announce Abstracts Accepted for Poster Presentation at the 42nd Annual Fall Clinical Dermatology Conference® October 14, 2022 8:30 AM - Globe NewsWire Novan and EPI Health, a Novan Company, Announce Abstracts Accepted for Poster Presentation at the 42nd Annual Fall Clinical Dermatology Conference® October 14, 2022 8:30 AM - StreetInsider Form 6-K NOVARTIS AG For: Sep 21 September 21, 2022 6:05 AM - SEC Filing EPI Health, a Novan Company, and MC2 Therapeutics Present WYNZORA® (calcipotriene and betamethasone dipropionate) Cream, 0.005%/0.064% Subgroup Data Analysis at Skin of Color Update 2022 Conference September 15, 2022 8:00 AM - Globe NewsWire EPI Health, a Novan Company, and MC2 Therapeutics Present WYNZORA® (calcipotriene and betamethasone dipropionate) Cream, 0.005%/0.064% Subgroup Data Analysis at Skin of Color Update 2022 Conference September 15, 2022 8:00 AM - StreetInsider Full Article List